Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H REICH

Showing results (331-340 of 349) with videos related to

Pageof 35
Sort By:
Journal of Medicinal Chemistry|July 21, 1998
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacementsS E Webber, K Okano, T L Little, et al.
American Journal of Medical Genetics. Part A|November 26, 2009
Genome-wide linkage scan of nonsyndromic orofacial clefting in 91 families of central European originElisabeth Mangold, Heiko Reutter, Stefanie Birnbaum, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 20, 2012
Resequencing of VAX1 in patients with nonsyndromic cleft lip with or without cleft palateEntessar Nasser, Elisabeth Mangold, Daniela C Tradowsky, et al.
Journal of Medicinal Chemistry|May 30, 2020
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA HelicaseJustin T Ernst, Peggy A Thompson, Christian Nilewski, et al.
European Journal of Oral Sciences|February 4, 2010
IRF6 gene variants in Central European patients with non-syndromic cleft lip with or without cleft palateStefanie Birnbaum, Kerstin U Ludwig, Heiko Reutter, et al.
Journal of Medicinal Chemistry|May 3, 2002
Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C proteaseTheodore O Johnson, Ye Hua, Hiep T Luu, et al.
Journal of Medicinal Chemistry|December 16, 1997
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 proteaseS W Kaldor, V J Kalish, J F Davies, et al.
Molecular Cancer Therapeutics|October 10, 2020
Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4APeggy A Thompson, Boreth Eam, Nathan P Young, et al.
BMC Cancer|November 1, 2019
A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer CenterMarie K Budde, Walther Kuhn, Mignon-Denise Keyver-Paik, et al.
Pageof 35

Showing results (331-340 of 349) with videos related to

Sort By:
Pageof 35
Journal of Medicinal Chemistry|July 21, 1998
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacementsS E Webber, K Okano, T L Little, et al.
American Journal of Medical Genetics. Part A|November 26, 2009
Genome-wide linkage scan of nonsyndromic orofacial clefting in 91 families of central European originElisabeth Mangold, Heiko Reutter, Stefanie Birnbaum, et al.
Nature Medicine|January 16, 2019
Translation control of the immune checkpoint in cancer and its therapeutic targetingYichen Xu, Mauro Poggio, Hyun Yong Jin, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 20, 2012
Resequencing of VAX1 in patients with nonsyndromic cleft lip with or without cleft palateEntessar Nasser, Elisabeth Mangold, Daniela C Tradowsky, et al.
Journal of Medicinal Chemistry|May 30, 2020
Design of Development Candidate eFT226, a First in Class Inhibitor of Eukaryotic Initiation Factor 4A RNA HelicaseJustin T Ernst, Peggy A Thompson, Christian Nilewski, et al.
European Journal of Oral Sciences|February 4, 2010
IRF6 gene variants in Central European patients with non-syndromic cleft lip with or without cleft palateStefanie Birnbaum, Kerstin U Ludwig, Heiko Reutter, et al.
Journal of Medicinal Chemistry|May 3, 2002
Structure-based design of a parallel synthetic array directed toward the discovery of irreversible inhibitors of human rhinovirus 3C proteaseTheodore O Johnson, Ye Hua, Hiep T Luu, et al.
Journal of Medicinal Chemistry|December 16, 1997
Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 proteaseS W Kaldor, V J Kalish, J F Davies, et al.
Molecular Cancer Therapeutics|October 10, 2020
Targeting Oncogene mRNA Translation in B-Cell Malignancies with eFT226, a Potent and Selective Inhibitor of eIF4APeggy A Thompson, Boreth Eam, Nathan P Young, et al.
BMC Cancer|November 1, 2019
A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer CenterMarie K Budde, Walther Kuhn, Mignon-Denise Keyver-Paik, et al.
Pageof 35